Van Andel Institute
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Van Andel Institute
Novel therapeutic strategies for Parkinson’s disease have brought a renewed sense of optimism to those researching this neurodegenerative disorder. Numerous treatment avenues are being explored, including small molecules, gene therapy, cell therapy and medical devices to stimulate nerves deep in the brain. Digital also gets a look-in, being useful for analyzing gait and other symptoms, and addressing both mental and physical issues.
START-UP’s monthly update on technology transfer deals—licensing agreements between companies and universities or other research institutions—in the fields of in vitro diagnostics, medical devices, pharmaceuticals, and research/analytical equipment & supplies.
- Academic and Research Institutions